{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"In the Money with Amber Kanwar","title":"The Midterms, the Markets and a Surprising Opportunity in Healthcare","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/3df06960\"></iframe>","width":"100%","height":180,"duration":3225,"description":"The U.S. midterm elections are over, but what do the results mean for your portfolio? With Washington's political landscape shifting, investors are weighing the implications for stocks and the broader market. Could the election results set the stage for the next leg of the rally, and is healthcare emerging as one of the biggest opportunities?\nOn this episode of In the Money with Amber Kanwar, Paul MacDonald, President & Co-Chief Investment Officer at Harvest ETFs and head of Canada's largest healthcare ETF, explains why the midterms could be a turning point for healthcare stocks. Historically, the broader market has been positive 85% of the time six months after the midterms and 100% of the time one year later. But beyond politics, a bigger shift is underway. As investors rotate away from the crowded AI trade, money is flowing into healthcare, a sector that has spent years out of favour but is now showing signs of a comeback.\nWith healthcare valuations still attractive and earnings growth expected to accelerate in 2027, MacDonald makes the case for why the rally may just be getting started. He breaks down the impact of shifting U.S. healthcare policy, why medical technology stocks could offer some of the best opportunities and whether pharmaceutical companies can keep outperforming.\nIn the Mailbag, he weighs in on Pfizer (PFE), Moderna (MRNA), CVS Health (CVS), Bausch Health (BHC), Zoetis (ZTS) and Boston Scientific (BSX), including which beaten-down stocks could recover and which may still be value traps.\nIn Pro Picks, MacDonald reveals three healthcare stocks he believes offer compelling opportunities: Stryker (SYK), AbbVie (ABBV) and UnitedHealth Group (UNH). He explains why he's sticking with these names despite recent challenges and where he sees the potential for further upside.\nTimestamps\n0:00 Trailer\n2:07 Intro: healthcare’s comeback\n4:33 Paul MacDonald on the midterms and healthcare\n5:58 Is healthcare still an opportunity?\n7:59 Healthcare policy: what...","thumbnail_url":"https://img.transistorcdn.com/er9NR63MREFV6i2rlZX8f-yMY6gNSK83fNUOzBPoSt8/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zZmQy/OWMwNmEzY2Y0YTg1/NjM4MjQ3Y2NjMWYy/Zjk1My5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}